Plasmid-Based E6-Specific siRNA and Co-Expression of Wild-Type P53 Suppresses the Growth of Cervical Cancer in Vitro and in Vivo

Cancer Letters- Ireland

doi 10.1016/j.canlet.2013.02.034

Full Text

Abstract

Available in

Categories

Cancer Research

Date

July 1, 2013

Authors

Dennis J. Kopecko

Dhananjaya V. Kalvakolanu

Publisher

Elsevier BV

Related search

Knockdown of TRAF4 Expression Suppresses Osteosarcoma Cell Growth in Vitro and in Vivo

International Journal of Molecular Medicine

English

Effect of Β-Sitosterol on the Expression of HPV E6 and P53 in Cervical Carcinoma Cells

Wspolczesna Onkologia

Nuclear Medicine

English

Brd4 Inhibition Suppresses HPV16 E6 Expression and Enhances Chemoresponse: A Potential New Target in Cervical Cancer Therapy

International Journal of Cancer

Cancer Research

English

Co-Expression of ING4 and P53 Enhances Hypopharyngeal Cancer Chemosensitivity to Cisplatin in Vivo

Molecular Medicine Reports

Molecular Biology

Cancer Research

Molecular Medicine

English

Adenovirus-Mediated Wild-Type P53 Overexpression Inhibits Endothelial Cell Differentiation in Vitro and Angiogenesis in Vivo

Molecular Medicine

Molecular Biology

English

miR-154 Suppresses Non-Small Cell Lung Cancer Growth in Vitro and in Vivo

Oncology Reports

Cancer Research

English

Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth in Vivo

Molecular Therapy - Nucleic Acids

Molecular Medicine

English

Three Prime Repair Exonuclease 1 (TREX1) Expression Correlates With Cervical Cancer Cells Growth in Vitro and Disease Progression in Vivo

Scientific Reports

Multidisciplinary

English

A Small Molecule Inhibitor of the Β-Catenin-Tcf4 Interaction Suppresses Colorectal Cancer Growth in Vitro and in Vivo

Molecular Biology

English